{
    "2021-03-09": [
        [
            {
                "time": "",
                "original_text": "国盛证券----医药生物行业周报：全民免疫迫在眉睫，新冠疫苗的热点问题怎么看【行业研究】",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全民免役",
                        "新冠疫苗",
                        "热点问题",
                        "行业研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}